Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
Thought that did not apply as contract was in place with an approved supplier prior to further approval
Easy well picked up ALL (gold standard) antigen tests offered will be gold standard….looks like they have cleared their back stock.
Interesting question why would you choose Astra Zeneca as the comparison with NFX. If you Google the biggest it is GSK and the largest market share is Pfizer. So a not so subliminal message misleading with the content? Then again did not AZ buy into Redx? AZ may be as interested in NXP002 as well as NXP004. Teasing choice from coincidently where AB last worked, coincidence, coincidence and not that well scripted, so a spoof clue. What are the chances to wet a lth appetite?
Soup agree also means the results have been in long enough to generate and submit the patent, lot going on under wraps, NXP002?
Soup yes agree it also means the results have been in long enough to prepare and submit the patent application so a lot going on in the background under wraps, NXP002?
Hate to say this guys but in one of the interviews it was said if the results of NXP004 was positive it would result in further patent applications prior to discussions with interested parties. Anyway results must have been good for the application to happen
Think I just got my quartile deviation wrong that is the gin, had a tough week, anyway news gets closer every day, astonishing would be nice
So when some says 4th Qtr it usually is not the end of the year ie Dec. 37 days in with a max of 92 days. Mean is 46 with a quartile deviation of 11 days. So we have just entered for he 1st quartile of potential news.
DAM has over 100 clinics in the U.K and Europe and expanding
From the DAM website day 2 antigen test for incoming travellers is an in clinic professional test
“Fully Vaccinated Day 2 Antigen Test
Results within 2 hours
Bookings available from the 24th of October
More Info
The government has announced that from 24 October 2021 fully vaccinated international passengers arriving in England from countries not on the red list can take a Day 2 lateral flow test instead of the PCR version.
In Clinic
£29”
From the DAM website, the fit to fly antigen test is an in clinic test, not a self test.
“Fit to Fly | Lateral Flow Antigen Test
Government-recognised provider
Accepted by all airlines
Results delivered as fast as two hours
This test will not be accepted for travel to Singapore, Jamaica, Hong Kong.
This is an in-clinic test that is carried out by one of our clinicians. Please choose your appointment at the clinic that is most suitable.”
Significant international deal with potential international travel growth.
Interesting MMS narrowed the spread 1.85/1.9 last 10mins must have wanted to collect shares for the close
I haven’t looked at the DAM website in detail but it is significant that they have dropped the Hughes test for professional use, it indicates that with self test approval for ODX this is going only one way.
The Dam agreement is for exclusive use they are only going to use ODX tests
Announcements would have been agreed between the two companies prior to announcements and their compliance officers will be on the ball
Contracts would have been signed before the announcements
Sell into a rising bid so will we see a buy later, unusual for price not to fall
Curious our price is net down on the week when yesterday CK had sorted a European outlet which is exactly where our competitors want to be
CK has sought out a U.K./European partner so can now sell Europe/Global knowing U.K. approval will be coming. DAM agreement shows they are confident they have backed a test which they will use for international travel their key business